1 United Nations, Department of Economics and Social Affairs, Population Division, "World population prospects 2019"
2 van den Bussche H, "Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany" 11 : 101-, 2011
3 Moriarty F, "Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland : a repeated cross-sectional study" 5 : e008656-, 2015
4 Cheong SJ, "The Effect of polypharmacy on mortality in the elderly" 6 : 643-650, 2016
5 Park BJ, "Study on diagnosis accuracy for health insurance claims data in Korea, report to Health Insurance Review and Assessment Services" Medical School of Seoul National University 17-29, 2003
6 Slabaugh SL, "Prevalence and risk of polypharmacy among the elderly in an outpatient setting : a retrospective cohort study in the Emilia-Romagna region, Italy" 27 : 1019-1028, 2010
7 Kim HA, "Prevalence and predictors of polypharmacy among Korean elderly" 9 : e98043-, 2014
8 Lees J, "Polypharmacy in elderly patients with cancer : clinical implications and management" 12 : 1249-1257, 2011
9 Hajjar ER, "Polypharmacy in elderly patients" 5 : 345-351, 2007
10 Gnjidic D, "Polypharmacy cutoff and outcomes : five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes" 65 : 989-995, 2012
1 United Nations, Department of Economics and Social Affairs, Population Division, "World population prospects 2019"
2 van den Bussche H, "Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany" 11 : 101-, 2011
3 Moriarty F, "Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland : a repeated cross-sectional study" 5 : e008656-, 2015
4 Cheong SJ, "The Effect of polypharmacy on mortality in the elderly" 6 : 643-650, 2016
5 Park BJ, "Study on diagnosis accuracy for health insurance claims data in Korea, report to Health Insurance Review and Assessment Services" Medical School of Seoul National University 17-29, 2003
6 Slabaugh SL, "Prevalence and risk of polypharmacy among the elderly in an outpatient setting : a retrospective cohort study in the Emilia-Romagna region, Italy" 27 : 1019-1028, 2010
7 Kim HA, "Prevalence and predictors of polypharmacy among Korean elderly" 9 : e98043-, 2014
8 Lees J, "Polypharmacy in elderly patients with cancer : clinical implications and management" 12 : 1249-1257, 2011
9 Hajjar ER, "Polypharmacy in elderly patients" 5 : 345-351, 2007
10 Gnjidic D, "Polypharmacy cutoff and outcomes : five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes" 65 : 989-995, 2012
11 Herr M, "Polypharmacy and frailty : prevalence, relationship, and impact on mortality in a French sample of 2350 old people" 24 : 637-646, 2015
12 Payne RA, "Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care" 77 : 1073-1082, 2014
13 Hovstadius B, "Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008" 10 : 16-, 2010
14 Fried TR, "Health outcomes associated with polypharmacy in community-dwelling older adults : a systematic review" 62 : 2261-2272, 2014
15 Statistics Korea, "Elderly statistics 2018" Statistics Korea
16 Nobili A, "Drug utilization and polypharmacy in an Italian elderly population : the EPIFARM-elderly project" 20 : 488-496, 2011
17 Kim AR, "Assessment of polypharmacy and potentially inappropriate medication in elderly outpatients" Ewha Womans Univ 2015
18 McLean AJ, "Aging biology and geriatric clinical pharmacology" 56 : 163-184, 2004
19 World Health Organization, "A glossary of terms for community health care and services for older persons"